228 filings
Page 2 of 12
8-K
ak3 clbuuoqkk9j
4 Jan 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:04pm
8-K
70rd7e3elvq
9 Nov 22
Lexicon Pharmaceuticals Reports Third Quarter 2022
4:05pm
8-K
ootnmy4p5jj5u
2 Sep 22
Entry into a Material Definitive Agreement
4:01pm
8-K
n2vazcy6to5k
2 Aug 22
Lexicon Pharmaceuticals Reports Second Quarter 2022
4:07pm
8-K
7br0x
29 Jul 22
Lexicon Announces Proposed Public Offering of Common Stock
5:18pm
8-K
nu4jcx9x3w5p1cy6ojr
30 Jun 22
Lexicon Announces Positive Top-line Results from Phase 2 Proof-of-concept Study of LX9211 In Painful Diabetic Neuropathy
12:52pm
8-K
i87ty
25 May 22
Material Modifications to Rights of Security Holders
8:27am
8-K
4b8msjln
5 May 22
Lexicon Pharmaceuticals Reports First Quarter 2022
6:10am
8-K
kceimk7qyfz
17 Mar 22
Entry into a Material Definitive Agreement
4:17pm
8-K
s3kl5vkh
28 Feb 22
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-year 2021 Financial Results and Provides Clinical Update
6:17am
8-K
erru9f916hdqwkrzp3
3 Nov 21
Lexicon Pharmaceuticals Reports Third Quarter 2021
4:05pm
8-K
jj9txso 75fpiivvf2pk
9 Sep 21
Departure of Directors or Certain Officers
4:10pm
8-K
djj4 hq5eq
2 Aug 21
Departure of Directors or Certain Officers
7:23am
8-K
t6e91i3dvn3ymf0h
2 Aug 21
Lexicon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical Update
7:20am
8-K
m3v7qd7
30 Jul 21
Results of Operations and Financial Condition
7:52am
8-K
fphk9ctwu8ag02c
30 Jul 21
Departure of Directors or Certain Officers
7:12am
8-K
tcvc rtqym1dlc42hv1
6 May 21
Lexicon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical Update
4:11pm
8-K
ge3b3g8
3 May 21
Entry into a Material Definitive Agreement
4:08pm
8-K
frussc8jls0
1 Apr 21
Departure of Directors or Certain Officers
4:36pm
8-K
vd6sthgg7f7s fbqh41
10 Mar 21
Lexicon Pharmaceuticals Reports Fourth Quarter and Full-year 2020 Financial Results and Provides Clinical Update
4:12pm